Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Necrosis01:16

Necrosis

3.7K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.7K
Neural Regulation01:37

Neural Regulation

39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

323
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Long-term Depression01:03

Long-term Depression

2.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

319
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
319

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Revised Classification of Primary Iron Overload Syndromes.

Journal of clinical and translational hepatology·2024
Same author

Distinctive chaperonopathy in skeletal muscle associated with the dominant variant in DNAJB4.

Acta neuropathologica·2022
Same author

Taurine depletion during fetal and postnatal development blunts firing responses of neocortical layer II/III pyramidal neurons.

Frontiers in molecular neuroscience·2022
Same author

Cognitive Impairment in a Complex Family With AAGGG and ACAGG Repeat Expansions in RFC1 Detected by ExpansionHunter Denovo.

Neurology. Genetics·2022
Same author

Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic Disorders.

Movement disorders clinical practice·2022
Same author

Nicotinic acetylcholine receptor agonist reduces acute lung injury after renal ischemia-reperfusion injury by acting on splenic macrophages in mice.

American journal of physiology. Renal physiology·2022

Related Experiment Video

Updated: May 13, 2025

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

7.9K

[Neurodegeneration Associated with Metal Metabolism].

Hiroaki Miyajima1

  • 1Tenryu-Kohseikai Clinic.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 12, 2025
PubMed
Summary

Neurodegeneration with brain iron accumulation (NBIA) is linked to copper metabolism disorders. Reduced ceruloplasmin levels in serum are a key indicator in NBIA, Wilson

Area of Science:

  • Neurobiology
  • Genetics
  • Metabolic Disorders

Background:

  • Neurodegeneration with brain iron accumulation (NBIA) is a group of inherited disorders.
  • NBIA is characterized by movement disorders and abnormal iron buildup in the basal ganglia.
  • Ten NBIA-associated genes have been identified, with aceruloplasminemia linked to copper metabolism.

Purpose of the Study:

  • To explore the role of ceruloplasmin in NBIA and its connection to copper metabolism.
  • To understand the molecular pathogenesis of NBIA and its implications for brain iron and copper pathways.

Main Methods:

  • Review of existing literature on NBIA, aceruloplasminemia, Wilson's disease, and Menkes' disease.
  • Analysis of the role of ceruloplasmin in iron efflux and copper transport.

More Related Videos

Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS
09:51

Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS

Published on: April 13, 2016

15.1K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.3K

Related Experiment Videos

Last Updated: May 13, 2025

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

7.9K
Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS
09:51

Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS

Published on: April 13, 2016

15.1K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.3K
  • Examination of serum ceruloplasmin levels in patients with related neurodegenerative conditions.
  • Main Results:

    • Aceruloplasminemia is a form of NBIA directly associated with copper metabolism.
    • Ceruloplasmin plays a critical role in iron efflux from mammalian cells.
    • Decreased serum ceruloplasmin levels are observed in aceruloplasminemia, Wilson's disease, and Menkes' disease.

    Conclusions:

    • The molecular pathogenesis of NBIA involves disruptions in brain iron and copper metabolism.
    • Ceruloplasmin deficiency is a significant factor in certain NBIA forms, highlighting the interplay between copper and iron.
    • Further research into these metabolic pathways can offer new insights into NBIA and related neurodegenerative diseases.